Tian Ding, Ph.D. - Publications
Affiliations: | 2009 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Biostatistics Biology, Genetics, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Leng X, Ding T, Lin H, Wang Y, Wu Y, Arlinghaus RB. WITHDRAWN: Requirement of lipocalin 2 in breast cancer. Advances in Enzyme Regulation. PMID 19914274 DOI: 10.1016/J.Advenzreg.2009.10.001 | 0.444 | |||
2009 | Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Research. 69: 8579-84. PMID 19887608 DOI: 10.1158/0008-5472.Can-09-1934 | 0.504 | |||
2009 | Leng X, Ding T, Arlinghaus R. Requirement of lipocalin 2 for hematopoietic and solid tumor malignancies. Advances in Enzyme Regulation. 49: 142-6. PMID 19344630 DOI: 10.1016/J.Advenzreg.2009.01.010 | 0.458 | |||
2008 | Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S, Sun T, Zhou Y, Monaco P, Belmont J, Aderem A, Akira S, Strong R, Arlinghaus R. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 27: 6110-9. PMID 18663364 DOI: 10.1038/Onc.2008.209 | 0.449 | |||
Show low-probability matches. |